...
首页> 外文期刊>Chest >Oropharyngeal Cleansing With 0.2% Chlorhexidine for Prevention of Nosocomial Pneumonia in Critically Ill Patients
【24h】

Oropharyngeal Cleansing With 0.2% Chlorhexidine for Prevention of Nosocomial Pneumonia in Critically Ill Patients

机译:0.2%氯己定清洗口咽以预防重症患者的医院内肺炎

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Oral cleansing with chlorhexidine decreases the incidence of nosocomial pneumonia in patients after cardiac surgery. However, evidence of its benefit in ICU patients is conflicting. Methods: Patients admitted to the ICU of an Indian tertiary care teaching hospital were randomized to twice-daily oropharyngeal cleansing with 0.2% chlorhexidine or 0.01% potassium permanganate (control) solution. Effects on the incidence of nosocomial pneumonia during ICU stay (primary outcome) and length of ICU stay and in-hospital mortality (secondary outcomes) were studied. Results: Five hundred twelve patients were randomized to either the chlorhexidine group (n = 250) or the control group (n = 262). Of the 471 subjects who completed the protocol, nosocomial pneumonia developed in 16 of 224 subjects (7.1%) in the chlorhexidine group and 19 of 247 subjects (7.7%) in the control group (p = 0.82; relative risk, 0.93; 95% confidence interval, 0.49 to 1.76); intention-to-treat analysis of 21 patients in whom the cleansing protocol was not followed revealed similar results. There was no significant difference between the study and control groups in the median day of development of pneumonia (5.0 days: interquartile range [IQR], 3.0 to 7.7 vs 5.0 days: IQR, 3.0 to 6.0, respectively), median ICU stay (5.0 days: IQR, 3.0 to 8.0 vs 6.0 days: IQR, 3.0 to 8.0, respectively), and mortality (34.8% vs 28.3%, respectively). On subgroup analysis, there was no significant difference in the primary and secondary outcomes in patients on mechanical ventilation, tracheal intubation, and coma (Glasgow coma scale ≤ 8). During the study period, nosocomial pneumonia developed in fewer subjects (35 of 471 subjects [7.4%]) than in the 3 months preceding and following the study (98 of 452 subjects [21.7%]; p < 0.001; relative risk, 0.34; 95% confidence interval, 0.24 to 0.49). Conclusions: Oropharyngeal cleansing with 0.2% chlorhexidine solution was not superior to oral cleansing with the control solution. However, the decreased incidence of nosocomial pneumonia during the study period suggests a possible benefit of meticulous oral hygiene in ICU patients.
机译:背景:洗必泰口服清洁剂可降低心脏手术后患者医院内肺炎的发生率。但是,其在ICU患者中获益的证据相互矛盾。方法:将印度三级护理教学医院的重症监护病房(ICU)入院的患者随机分为两组,每天口服两次,用0.2%洗必太或0.01%高锰酸钾(对照)溶液清洗口咽。研究了对ICU住院期间(主要结局),ICU住院时间和住院死亡率(继发结局)对医院内肺炎发生率的影响。结果:512名患者被随机分配到洗必泰组(n = 250)或对照组(n = 262)。在完成方案的471名受试者中,洗必泰组的224名受试者中有16名(7.1%)发生了医院内肺炎,对照组的247名受试者中有19名(7.7%)发生了肺炎(p = 0.82;相对危险度为0.93; 95%置信区间为0.49至1.76);对未遵循清洁方案的21位患者进行意向治疗分析显示了相似的结果。在研究组和对照组之间,在肺炎发生的中位数天(5.0天:四分位间距[IQR],分别为3.0至7.7和5.0天:IQR,3.0至6.0天),中位ICU停留时间(5.0天)无显着差异天:IQR,3.0至8.0与6.0天:IQR,分别为3.0至8.0)和死亡率(分别为34.8%和28.3%)。在亚组分析中,机械通气,气管插管和昏迷(格拉斯哥昏迷评分≤8)患者的主要和次要结局无显着差异。在研究期间,与研究前和研究后三个月(452名受试者中的98名[21.7%])相比,更少的受试者(471名受试者中的35名[7.4%])发生了医院内肺炎(p <0.001;相对危险度为0.34; p <0.001)。 95%置信区间(0.24至0.49)。结论:用0.2%洗必泰溶液清洁口咽并不优于使用对照溶液进行口腔清洁。但是,在研究期间,医院内肺炎的发病率下降表明,对ICU患者进行细致的口腔卫生可能具有一定的益处。

著录项

  • 来源
    《Chest》 |2009年第5期|1150-1156|共7页
  • 作者单位

    From the Medical-Neuro Intensive Care Unit, Department of Medicine, Seth GS Medical College and King Edward VII Memorial Hospital, Mumbai, India.;

    From the Medical-Neuro Intensive Care Unit, Department of Medicine, Seth GS Medical College and King Edward VII Memorial Hospital, Mumbai, India.;

    From the Medical-Neuro Intensive Care Unit, Department of Medicine, Seth GS Medical College and King Edward VII Memorial Hospital, Mumbai, India.;

    From the Medical-Neuro Intensive Care Unit, Department of Medicine, Seth GS Medical College and King Edward VII Memorial Hospital, Mumbai, India.;

    From the Medical-Neuro Intensive Care Unit, Department of Medicine, Seth GS Medical College and King Edward VII Memorial Hospital, Mumbai, India.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号